Related Experiment Video
Updated: Sep 26, 2026

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
The Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin
Manuela Schuetzer-Muehlbauer1, Birgit Willinger, Gerd Krapf
1Institute of Medical Biochemistry, Department of Molecular Genetics, University and BioCenter of Vienna, Dr Bohr-Gasse 9/2, A-1030 Vienna, Austria.
Abstract:
Multidrug resistance may pose a serious problem to antifungal therapy. The Candida albicans Cdr2p is one of two ATP-binding cassette (ABC) transporters mediating antifungal resistance in vivo through increased drug efflux. Echinocandins such as caspofungin represent the newest class of antifungals that target cell wall synthesis. We show here by agar plate resistance assays that cross-resistant clinical isolates of C. albicans display high minimal inhibitory concentrations (MICs) to caspofungin when compared with a sensitive ATCC reference strain. Northern analysis and immunoblotting indicate that these isolates also show high levels of CDR1 and CDR2 expression. To determine a possible contribution of Cdr1p or Cdr2p to caspofungin resistance, we have functionally expressed Cdr1p and Cdr2p in appropriate recipient strains of the yeast Saccharomyces cerevisiae. Yeast cells expressing Cdr1p or Cdr2p exhibit cross-resistance to established antifungal drugs such as azoles and terbinafine. However, Cdr2p and, to a much lesser extent, Cdr1p confer caspofungin hyper-resistance when expressed in yeast. Likewise, Cdr2p confers caspofungin resistance when constitutively overexpressed in a drug-sensitive C. albicans strain. We therefore propose that Cdr2p may contribute to clinical candin resistance. Finally, our data suggest that cross-resistance phenotypes of clinical isolates are the consequence of distinct mechanisms that may operate simultaneously.
Insights
Candida albicans Cdr2p, an ABC transporter, contributes to caspofungin resistance by increasing drug efflux. This finding is crucial for understanding and combating antifungal drug resistance in clinical settings.
Area of Science:
- Medical Mycology
- Molecular Biology
- Antimicrobial Resistance
Background:
- Multidrug resistance is a significant challenge in antifungal therapy.
- Candida albicans possesses ATP-binding cassette (ABC) transporters, including Cdr2p, that mediate antifungal resistance via drug efflux.
- Echinocandins, like caspofungin, are a new class of antifungals targeting fungal cell wall synthesis.
Purpose of the Study:
- To investigate the role of Candida albicans Cdr2p in caspofungin resistance.
- To determine if Cdr2p contributes to cross-resistance phenotypes observed in clinical isolates.
- To elucidate the mechanisms underlying antifungal drug resistance.
Main Methods:
- Agar plate resistance assays to determine minimal inhibitory concentrations (MICs).
- Northern analysis and immunoblotting to assess CDR1 and CDR2 gene expression levels.
- Functional expression of Cdr1p and Cdr2p in Saccharomyces cerevisiae recipient strains.
- Constitutive overexpression of Cdr2p in a drug-sensitive C. albicans strain.
Main Results:
- Clinical isolates of C. albicans with cross-resistance showed high MICs to caspofungin.
- These isolates exhibited elevated CDR1 and CDR2 expression.
- Expression of Cdr2p, and to a lesser extent Cdr1p, in yeast conferred cross-resistance to azoles and terbinafine.
- Cdr2p expression led to hyper-resistance to caspofungin in yeast and in C. albicans.
- Constitutive overexpression of Cdr2p in C. albicans also conferred caspofungin resistance.
Conclusions:
- Cdr2p, an ABC transporter in Candida albicans, plays a significant role in conferring resistance to caspofungin.
- Cdr2p may contribute to clinical echinocandin resistance.
- The observed cross-resistance phenotypes in clinical isolates likely result from multiple, potentially simultaneous, resistance mechanisms.
Related Concept Videos
Candidiasis
Antifungal Agents
ABC Transporters: Exporter
Cryptococcal Meningitis

